Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H27N3O2 |
| Molecular Weight | 377.4794 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(NC(=O)C1=NN(CC2CCOCC2)C3=C1C=CC=C3)C4=CC=CC=C4
InChI
InChIKey=HINCNLQQLQFMRD-UHFFFAOYSA-N
InChI=1S/C23H27N3O2/c1-23(2,18-8-4-3-5-9-18)24-22(27)21-19-10-6-7-11-20(19)26(25-21)16-17-12-14-28-15-13-17/h3-11,17H,12-16H2,1-2H3,(H,24,27)
| Molecular Formula | C23H27N3O2 |
| Molecular Weight | 377.4794 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:50:15 UTC 2023
by
admin
on
Sat Dec 16 11:50:15 UTC 2023
|
| Record UNII |
6R5GTC3QVB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-CUMYL-THPINACA
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID401032565
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
PRIMARY | |||
|
CUMYL-THPINACA
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
PRIMARY | CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors. Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014. As of October 2015 CUMYL-THPINACA is a controlled substance in China. | ||
|
86273679
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
PRIMARY | |||
|
6R5GTC3QVB
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
PRIMARY | |||
|
1400742-50-8
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
PRIMARY | |||
|
CUMYL-THPINACA
Created by
admin on Sat Dec 16 11:50:16 UTC 2023 , Edited by admin on Sat Dec 16 11:50:16 UTC 2023
|
PRIMARY | AB-CHMINACA (Item No. 15434) in a synthetic cannabinoid (CB) featuring a 1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (CHMINACA) base. It displays a 10-fold greater affinity for the central CB1 receptor (Ki = 0.9 nM) than that of JWH 018 (Item No. 10900).1,2 CUMYL-THPINACA RM is a derivative of AB-CHMINACA in which the cyclohexylmethyl group is replaced with a tetrahydropyranyl methyl group. The aminomethyloxobutanyl group of AB-CHMINACA is replaced with a cumyl group. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
